Phase I/II study of tolerogenic vaccine

Trial Profile

Phase I/II study of tolerogenic vaccine

Planning
Phase of Trial: Phase I/II

Latest Information Update: 30 Dec 2016

At a glance

  • Drugs Vaccines (Primary)
  • Indications Haemophilia A
  • Focus Adverse reactions; First in man
  • Most Recent Events

    • 30 Dec 2016 New trial record
    • 14 Dec 2016 According to an Idogen media release, company had a successful scientific advice meeting with the Swedish Medical Products Agency regarding the proposed design of this study.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top